Editor's Note The Food and Drug Administration (FDA) authorized updated versions of the Moderna and Pfizer-BioNTech vaccines with the goal of protecting against the recent Omicron variant, NPR August 31 reports. The updated booster, called a bivalent vaccine, offers protection from both the original strain of COVID-19 and the most…

Read More

Editor's Note On Friday, August 26, the vaccine manufacturer Moderna sued Pfizer and the German drugmaker BioNTech, accusing its competitors of copying technology that Moderna had developed prior to the pandemic, The New York Times August 26 reports. The patent infringement claims could result in a protracted and expensive legal battle…

Read More

Editor's Note In this study, researchers at NYC Health + Hospitals, New York City, evaluate how uptake of COVID-19 booster doses among fully vaccinated US adults varied by geographic location, occupation, and sociodemographic characteristics. Receipt of a booster was defined as taking two or more doses of COVID-19 vaccines with…

Read More

Editor's Note  On Friday, August 12, the New York State Department of Health and the New York City Department of Health and Mental Hygiene announced that polio (poliomyelitis) was detected in local wastewater, Becker’s Hospital Review August 15 reports. "For every one case of paralytic polio identified, hundreds more may…

Read More

Editor's Note This study led by researchers at Beth Israel Deaconess Medical Center, Boston, finds that being boosted with either the Janssen (Johnson & Johnson) or Pfizer-BioNTech vaccine was associated with increased humoral and cellular immune responses. Boosting with the Janssen vaccine also was associated with durable antibody and T-cell…

Read More

Editor's Note On Tuesday, August 9, US officials announced they will modify dosing instructions for the Jynneos monkeypox vaccine to stretch the supply, US News & World Report July 10 reports. Currently, there are almost 9,500 known cases in the US, predominantly among gay and bisexual men. According to the…

Read More

Editor's Note  US government researchers found that lab-engineered antibody has protected the majority of participants from the malaria parasite, including those who received a higher dosage of the antibody, US News & World August 4 reports. The antibody can also be given with a standard injection, instead of the typical…

Read More

Editor's Note The Biden administration will begin a COVID-19 booster campaign for revamped vaccines in September, the New York Times July 28 reports. This new booster is predicted to provide more extensive protection against the Omicron subvariants. Federal officials made the decision that individuals over 50 and those over 12…

Read More

Editor's Note On July 23, the World Health Organization (WHO) director-general declared monkeypox a public health emergency of international concern following the agency’s emergency committee inability to reach a consensus, Becker’s Hospital Review July 25 reports. After the no conclusion was drawn in the most recent meeting, WHO Director-General Dr…

Read More

Editor's Note On July 19, Centers for Disease Control and Prevention (CDC) advisers said the 26 to 37 million adults in the US who have yet to get a COVID-19 vaccination should consider the “more traditional” vaccine Novavax, Modern Healthcare July 19 reports. Novavax is the “first so-called protein vaccine”…

Read More